GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study
GnRHa Trigger in Asian Oocyte Donors Co-treated With a GnRH Antagonist - a Dose Finding Study
Sponsor: Aarhus University Hospital
Listed as NCT02208986, this NA trial focuses on Normal Oocyte Donors and remains completed. Sponsored by Aarhus University Hospital, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Jun 2022 [monthly]
Completed NA
-
Jun 2019 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Jun 2018 — Jun 2019 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Aug 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital
- Merck Sharp & Dohme LLC
- The Fertility Clinic, Skive Regional Hospital, Denmark
- University of Southern Denmark
- Vietnam National University
For direct contact, visit the study record on ClinicalTrials.gov .